News from dyadic international, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Mar 18, 2015, 16:15 ET

Dyadic International Announces The Appointment Of Jack Kaye To Its Board of Directors

Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI) today announced the appointment of Jack Kaye to the Board of Directors, effective April 1,...

Mar 11, 2015, 16:15 ET

Dyadic International Reports 2014 Year End Financial Results

 Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), a global biotechnology company whose patented and proprietary technologies are used to...

Mar 09, 2015, 08:30 ET

Dyadic International Raises $2 Million In Private Placement Of Convertible Note

 Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), a global biotechnology company whose patented and proprietary technologies are used to...

Feb 26, 2015, 09:15 ET

Dyadic International To Announce Fourth Quarter 2014 Financial Results And Host Conference Call On Wednesday, March 11, 2015

 Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), a global biotechnology company whose patented and proprietary technologies are used to...

Jan 12, 2015, 08:40 ET

Dyadic Appoints Michael Tarnok As Chairman Of The Board Of Directors

 Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), a global biotechnology company focused on the discovery, development, manufacture and...

Jan 05, 2015, 16:15 ET

Dyadic International Extends Debt Maturity Date On Note Payable

Dyadic International, Inc. ("Dyadic")(OTCQX: DYAI), a global biotechnology company whose patented and proprietary technologies are used to develop,...

Nov 13, 2014, 16:15 ET

Dyadic International Reports Q3 2014 Financial Results

JUPITER, Fla., Nov. 13, 2014 /PR Newswire/ - Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), a global biotechnology company whose patented and...

Nov 12, 2014, 09:34 ET

New U.S. Patent Issued To Dyadic International

 Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), a global biotechnology company whose patented and proprietary technologies are used to...

Nov 03, 2014, 16:48 ET

Dyadic International To Present At Two Conferences In November 2014

Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), a global biotechnology company whose patented and proprietary technologies are used to...

Oct 30, 2014, 17:42 ET

Dyadic International Extends All Convertible Debt Maturity Dates

Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), a global biotechnology company whose patented and proprietary technologies are used to...

Oct 30, 2014, 16:50 ET

Dyadic International To Announce Third Quarter 2014 Financial Results And Host Conference Call On Thursday, November 13, 2014

Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), a global biotechnology company whose patented and proprietary technologies are used to...

Oct 01, 2014, 08:30 ET
Dyadic Corporate logo.  (PRNewsFoto/Dyadic International, Inc.)

Dyadic International Reports Licensing Payment For Commercial-Scale Production Of C1-Based Cellulase Enzymes

 Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), a global biotechnology company with patented and proprietary technology used to develop...

Aug 18, 2014, 08:47 ET
Dyadic Corporate logo.  (PRNewsFoto/Dyadic International, Inc.)

Dyadic International Files Form 10 Registration Statement

Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), a global biotechnology company whose patented and proprietary technologies are used to...

Aug 14, 2014, 16:42 ET
Dyadic Corporate logo.  (PRNewsFoto/Dyadic International, Inc.)

Dyadic International Reports Q2 2014 Financial Results

 Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), a global biotechnology company whose patented and proprietary technologies are used to...

Aug 05, 2014, 08:30 ET
Dyadic Corporate logo.  (PRNewsFoto/Dyadic International, Inc.)

Dyadic And CIMV Enter Into Collaboration To Commercialize Second Generation Biofuel Technology

Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), a global biotechnology company whose patented and proprietary technologies are used to...

Aug 01, 2014, 08:30 ET
Dyadic Corporate logo.  (PRNewsFoto/Dyadic International, Inc.)

Dyadic International To Announce Second Quarter 2014 Financial Results And Host Conference Call On Thursday, August 14, 2014

Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), a global biotechnology company whose patented and proprietary technologies are used to...

Jul 30, 2014, 08:30 ET
Dyadic Corporate logo.  (PRNewsFoto/Dyadic International, Inc.)

Thomas Dubinski joins Dyadic as Chief Financial Officer

 Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), is a global biotechnology company whose patented and proprietary technologies are used to...

Jul 09, 2014, 16:15 ET
Dyadic Corporate logo.  (PRNewsFoto/Dyadic International, Inc.)

Dyadic International Announces Participation In Bakenzyme Project

 Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), a global biotechnology company focused on the discovery, development, manufacture and...

Jun 16, 2014, 16:15 ET
Dyadic Corporate logo.  (PRNewsFoto/Dyadic International, Inc.)

Dyadic Added to Biofuel Digest Index of Bioeconomy Stocks

Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of...

Jun 12, 2014, 09:15 ET
Dyadic Corporate logo.  (PRNewsFoto/Dyadic International, Inc.)

Dyadic Appoints Michael Tarnok, Chairman Of Keryx And Former Pfizer Senior Vice President, To Board Of Directors

 Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), a global biotechnology company focused on the discovery, development, manufacture and...